{
  "version": 3,
  "sources": ["ssg:https://framerusercontent.com/modules/V0JAnRg4GiaEsAD8b1Tm/UK6tteK74R3c0FKJnYn3/TQI0aeoeE-6.js"],
  "sourcesContent": ["import{jsx as e,jsxs as i}from\"react/jsx-runtime\";import*as n from\"react\";export const richText=/*#__PURE__*/e(n.Fragment,{children:/*#__PURE__*/e(\"p\",{children:\"Exploring the latest in precision oncology with experts from Agilent, Genoox, and MGI. Learn how Agilent's SureSelect CGP Panel, powered by Genoox's Franklin AI platform and MGI's DNBSEQ\u2122 technology, is revolutionizing genetic analysis. Luciana De Cesare will showcase Franklin\u2019s capabilities in variant analysis, Chee Yang will introduce the SureSelect CGP portfolio for tumor profiling, and Reshma Suresh will discuss the versatility of DNBSEQ\u2122 technology. Enhance your genomic research and clinical outcomes with these cutting-edge tools.\"})});export const richText1=/*#__PURE__*/i(n.Fragment,{children:[/*#__PURE__*/e(\"p\",{children:\"Join us for an insightful webinar where we delve into the latest advancements in precision oncology, featuring industry-leading experts from Agilent, Genoox, and MGI. \"}),/*#__PURE__*/e(\"p\",{children:\"Discover how Agilent's SureSelect CGP Panel, integrated with Genoox's Franklin AI platform and MGI's cutting-edge DNBSEQ\u2122 technology, is transforming the landscape of genetic analysis. Luciana De Cesare, Field Application Scientist at Genoox, will demonstrate how Franklin simplifies variant analysis and interpretation, providing actionable insights for both germline and somatic NGS data. Chee Yang, Senior Field Applications Scientist at Agilent, will explore the innovative SureSelect Cancer CGP portfolio, highlighting its capabilities in detecting critical somatic alterations and emerging biomarkers. \"}),/*#__PURE__*/e(\"p\",{children:\"Reshma Suresh, Product Manager at MGI, will introduce the versatile DNBSEQ\u2122 technology, showcasing its applications in sequencing. Attendees will gain practical knowledge on leveraging these technologies for comprehensive tumor profiling, enhancing their genomic research and clinical outcomes.\"})]});export const richText2=/*#__PURE__*/e(n.Fragment,{children:/*#__PURE__*/e(\"p\",{children:\"Discover how to simplify the diagnosis of monogenic hereditary diseases with advanced solutions. Learn practical steps and innovative methods to streamline genetic testing, making implementation easier and more efficient for healthcare providers.\"})});export const richText3=/*#__PURE__*/e(n.Fragment,{children:/*#__PURE__*/e(\"p\",{children:\"Discover how Comprehensive Molecular Tumor Analysis (CMTA) revolutionizes cancer treatment by integrating RNA-seq and Tumor Microenvironment (TME) data. Learn how this cutting-edge approach with MGI DNBSEQ technology offers precise, targeted therapies, enhancing personalized care and outcomes for cancer patients. Don't miss the chance to elevate your understanding and impact in oncology.\"})});export const richText4=/*#__PURE__*/e(n.Fragment,{children:/*#__PURE__*/e(\"p\",{children:\"Discover how (CMTA) revolutionizes cancer treatment. Learn how integrating RNA-seq and Tumor Microenvironment (TME) data with MGI DNBSEQ technology offers precise, targeted therapies, enhancing personalized care and patient outcomes.\"})});export const richText5=/*#__PURE__*/e(n.Fragment,{children:/*#__PURE__*/e(\"p\",{children:'Join Dr. Davide Cacchiarelli for an insightful talk on \"Population-based surveillance for inherited disorders.\" Discover innovative methods and strategies for monitoring and managing genetic conditions on a population level, enhancing early detection, and improving public health outcomes.'})});export const richText6=/*#__PURE__*/e(n.Fragment,{children:/*#__PURE__*/e(\"p\",{children:\"MGI's DNBSEQ\u2122 technology revolutionizes DNA sequencing by combining DNA Nanoballs (DNB) with high signal density chips for exceptional accuracy in WGS and WES. The process involves efficient DNA preparation, error-resistant amplification with Rolling Circle Replication, and high-throughput sequencing with cPAS technology. Advanced algorithms further enhance base call accuracy and data processing speed, making DNBSEQ\u2122 a powerful tool for genomics research.\"})});export const richText7=/*#__PURE__*/e(n.Fragment,{children:/*#__PURE__*/e(\"p\",{children:\"Discover the latest in MGI's DNBSEQ\u2122 technology with Q40 2.0 chemistry, achieving over 85% Q40 on multiple sequencers. Explore new Stereo-Seq solutions: Stereo-CITE Proteo-Transcriptomics and Stereo-Seq OMNI, advancing genomic research boundaries.\"})});export const richText8=/*#__PURE__*/e(n.Fragment,{children:/*#__PURE__*/e(\"p\",{children:\"Whole Genome Sequencing (WGS) is a process of sequencing the entire genome of an individual with an unknown genomic sequence. By utilizing high-throughput sequencing technologies, WGS can rapidly and cost-effectively determine the entire genome sequence of an organism. In this context, Erin Connolly-Strong will delve into the Clinics WGS application based on MGI's DNBSQ-T7, highlighting its potential and practical applications in cancer genomics and rare disease diagnosis.\"})});export const richText9=/*#__PURE__*/i(n.Fragment,{children:[/*#__PURE__*/e(\"p\",{children:\"Whole Genome Sequencing (WGS) is revolutionizing oncological research and treatment by providing a detailed view of the genomic alterations associated with cancer. Inocras\u2019s Cancer Vision platform utilizes WGS to transform DNA data intoaction.\"}),/*#__PURE__*/e(\"p\",{children:\"This talk will focus on the clinical applications of WGS, illustrating its utility in real-world settings. We aim to explore how these WGS-powered genomic insights facilitate a deeper understanding of tumor biology and aid in personalized treatment strategies.\"}),/*#__PURE__*/e(\"p\",{children:\"We will examine the integration of WGS into clinical practice, discussing specific cases and studies where WGS has aided clinical decisions. Key topics will include the detection of rare and complex mutations, the identification of actionable targets for therapy, and the role of WGS in identifying genomic signatures. The utilization of WGS in clinical oncology offers a transformative approach to cancer care, enabling a shift toward a more tailored treatment strategy.\"})]});export const richText10=/*#__PURE__*/e(n.Fragment,{children:/*#__PURE__*/e(\"p\",{children:\"Cancer is a major global health issue, responsible for about one-sixth of all deaths, surpassing the combined toll of AIDS, tuberculosis, and malaria. It ranks as the top cause of mortality in numerous countries. Technological progress, especially in genomics, has enhanced our grasp of cancer's triggers and fostered precision oncology. In this context, Dr. Marie-Laure Yaspo at ALACRIS Theranostics aims to bridge the care divide with scientifically-backed cancer management methods throughout the patient journey, from prevention to therapy, leveraging MGI's advanced life science tools.\"})});export const richText11=/*#__PURE__*/e(n.Fragment,{children:/*#__PURE__*/e(\"p\",{children:\"Launched in 2019, the Million Microbiome of Humans Project, a collaboration among scientists from 21 institutions across 10+ countries, aims to analyze 1 million microbial samples from various human organs within 3-5 years, using metagenomic sequencing to create the largest global human microbiome database.\"})});export const richText12=/*#__PURE__*/e(n.Fragment,{children:/*#__PURE__*/e(\"p\",{children:\"Comprehensive genomic profiling is essential for precision oncology. The speakers evaluated cancer gene panels on MGI's G400 and G99 DNBSEQ systems. Agilent's assay offers tumor profiling on G400; GenePLUS has a 1021-gene panel; NGeneBio targets 18-343 genes for various cancers. These systems achieve >90% Q30, >50X coverage, detecting variants down to 1% allele frequency. MGI's systems offer speed, scalability, and cost-effectiveness, supporting both large and targeted panels for cancer research and diagnostics, advancing genomic medicine.\"})});export const richText13=/*#__PURE__*/e(n.Fragment,{children:/*#__PURE__*/e(\"p\",{children:\"Unravel the mysteries of B and T cell expansions with cutting-edge TCR and BCR sequencing. Join us as we explore the latest advancements in RNA profiling, V(D)J analysis, and spatial biology technologies for comprehensive immune profiling.\"})});export const richText14=/*#__PURE__*/e(n.Fragment,{children:/*#__PURE__*/e(\"p\",{children:\"Alacris Theranostics' Comprehensive Molecular Tumor Analysis (CMTA) uses whole exome and transcriptome sequencing with MGI DNBSEQ technology. It's beneficial for guiding targeted therapies in complex or unknown tumors, enhancing personalized cancer treatment plans.\"})});export const richText15=/*#__PURE__*/e(n.Fragment,{children:/*#__PURE__*/e(\"p\",{children:\"Stereo-seq, based on DNA Nanoball (DNB) technology, offers spatially resolved, single-cell gene expression profiling in tissue slices. It supports advanced analysis in the Human Protein Atlas program, enhancing coverage and resolution. The webinar highlights its use in research, along with STOmics' new bioinformatic tools and automation system.\"})});export const richText16=/*#__PURE__*/e(n.Fragment,{children:/*#__PURE__*/e(\"p\",{children:\"Learn how Next-Generation Sequencing is reshaping agriculture, improving plant and animal breeding. Through case studies, we illustrate how NGS enables efficient selection, promoting faster, cost-effective breeding strategies.\"})});export const richText17=/*#__PURE__*/i(n.Fragment,{children:[/*#__PURE__*/e(\"p\",{children:\"Discover how we revolutionized high-throughput DNA sequencing into a crucial diagnostic tool at NoorDx, Saudi Arabia using MGI platforms, underscoring the significance of genome analysis in healthcare decisions.\"}),/*#__PURE__*/e(\"p\",{children:/*#__PURE__*/e(\"br\",{className:\"trailing-break\"})})]});export const richText18=/*#__PURE__*/e(n.Fragment,{children:/*#__PURE__*/e(\"p\",{children:\"Sequencing larger regions of the genome offers more information to clinicians looking for potential disease causing variants to help diagnose their patients. This webinar demonstrates the full workflow from sample to report generation covering, exome sequencing with MGI\u2019s DNBSeq-T7, NGS data analysis and interpretation with VarSome Clinical, and Gencell's approach and experience using both.\"})});\nexport const __FramerMetadata__ = {\"exports\":{\"richText17\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"richText10\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"richText2\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"richText8\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"richText1\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"richText18\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"richText12\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"richText7\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"richText3\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"richText11\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"richText9\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"richText5\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"richText15\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"richText\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"richText16\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"richText13\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"richText4\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"richText6\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"richText14\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"__FramerMetadata__\":{\"type\":\"variable\"}}}"],
  "mappings": "oFAAiF,IAAMA,EAAsBC,EAAIC,EAAS,CAAC,SAAsBD,EAAE,IAAI,CAAC,SAAS,8iBAA+hB,CAAC,CAAC,CAAC,EAAeE,EAAuBC,EAAIF,EAAS,CAAC,SAAS,CAAcD,EAAE,IAAI,CAAC,SAAS,yKAAyK,CAAC,EAAeA,EAAE,IAAI,CAAC,SAAS,umBAAkmB,CAAC,EAAeA,EAAE,IAAI,CAAC,SAAS,6SAAwS,CAAC,CAAC,CAAC,CAAC,EAAeI,EAAuBJ,EAAIC,EAAS,CAAC,SAAsBD,EAAE,IAAI,CAAC,SAAS,wPAAwP,CAAC,CAAC,CAAC,EAAeK,EAAuBL,EAAIC,EAAS,CAAC,SAAsBD,EAAE,IAAI,CAAC,SAAS,wYAAwY,CAAC,CAAC,CAAC,EAAeM,EAAuBN,EAAIC,EAAS,CAAC,SAAsBD,EAAE,IAAI,CAAC,SAAS,2OAA2O,CAAC,CAAC,CAAC,EAAeO,EAAuBP,EAAIC,EAAS,CAAC,SAAsBD,EAAE,IAAI,CAAC,SAAS,mSAAmS,CAAC,CAAC,CAAC,EAAeQ,EAAuBR,EAAIC,EAAS,CAAC,SAAsBD,EAAE,IAAI,CAAC,SAAS,udAA6c,CAAC,CAAC,CAAC,EAAeS,EAAuBT,EAAIC,EAAS,CAAC,SAAsBD,EAAE,IAAI,CAAC,SAAS,8PAAyP,CAAC,CAAC,CAAC,EAAeU,EAAuBV,EAAIC,EAAS,CAAC,SAAsBD,EAAE,IAAI,CAAC,SAAS,+dAA+d,CAAC,CAAC,CAAC,EAAeW,EAAuBR,EAAIF,EAAS,CAAC,SAAS,CAAcD,EAAE,IAAI,CAAC,SAAS,0PAAqP,CAAC,EAAeA,EAAE,IAAI,CAAC,SAAS,sQAAsQ,CAAC,EAAeA,EAAE,IAAI,CAAC,SAAS,ydAAyd,CAAC,CAAC,CAAC,CAAC,EAAeY,EAAwBZ,EAAIC,EAAS,CAAC,SAAsBD,EAAE,IAAI,CAAC,SAAS,glBAAglB,CAAC,CAAC,CAAC,EAAea,EAAwBb,EAAIC,EAAS,CAAC,SAAsBD,EAAE,IAAI,CAAC,SAAS,sTAAsT,CAAC,CAAC,CAAC,EAAec,EAAwBd,EAAIC,EAAS,CAAC,SAAsBD,EAAE,IAAI,CAAC,SAAS,miBAAmiB,CAAC,CAAC,CAAC,EAAee,EAAwBf,EAAIC,EAAS,CAAC,SAAsBD,EAAE,IAAI,CAAC,SAAS,iPAAiP,CAAC,CAAC,CAAC,EAAegB,EAAwBhB,EAAIC,EAAS,CAAC,SAAsBD,EAAE,IAAI,CAAC,SAAS,2QAA2Q,CAAC,CAAC,CAAC,EAAeiB,EAAwBjB,EAAIC,EAAS,CAAC,SAAsBD,EAAE,IAAI,CAAC,SAAS,4VAA4V,CAAC,CAAC,CAAC,EAAekB,EAAwBlB,EAAIC,EAAS,CAAC,SAAsBD,EAAE,IAAI,CAAC,SAAS,oOAAoO,CAAC,CAAC,CAAC,EAAemB,EAAwBhB,EAAIF,EAAS,CAAC,SAAS,CAAcD,EAAE,IAAI,CAAC,SAAS,qNAAqN,CAAC,EAAeA,EAAE,IAAI,CAAC,SAAsBA,EAAE,KAAK,CAAC,UAAU,gBAAgB,CAAC,CAAC,CAAC,CAAC,CAAC,CAAC,EAAeoB,EAAwBpB,EAAIC,EAAS,CAAC,SAAsBD,EAAE,IAAI,CAAC,SAAS,gZAA2Y,CAAC,CAAC,CAAC,EAC/5TqB,EAAqB,CAAC,QAAU,CAAC,WAAa,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,WAAa,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,UAAY,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,UAAY,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,UAAY,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,WAAa,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,WAAa,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,UAAY,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,UAAY,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,WAAa,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,UAAY,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,UAAY,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,WAAa,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,SAAW,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,WAAa,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,WAAa,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,UAAY,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,UAAY,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,WAAa,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,mBAAqB,CAAC,KAAO,UAAU,CAAC,CAAC",
  "names": ["richText", "p", "x", "richText1", "u", "richText2", "richText3", "richText4", "richText5", "richText6", "richText7", "richText8", "richText9", "richText10", "richText11", "richText12", "richText13", "richText14", "richText15", "richText16", "richText17", "richText18", "__FramerMetadata__"]
}